Loading data for ECOR — first visit, this takes a few seconds.

提醒

electroCore Inc. (ECOR)

NasdaqCM: ECOR · 即時價格 · USD

9.62

-0.09 (-0.93%)

收盤價： Aug 28, 2026, 3:59 PM

股價、關鍵數字和最新消息，都在這一頁。

-0.93% (1D)

買價	7.01
市值	87.81M
營收 (ttm)	36.97M
淨利（ttm）	-14.77M
	0.94
	-1.65
	n/a
	-17.71
P/B (ttm)	-31.42
P/S (ttm)	2.38
財報日期	Nov 4, 2026

賣價	11.89
成交量	87,117
20 日平均成交量	101,993
開盤價	9.99
前收盤價	9.71
當日區間	9.22 - 9.99
52 週範圍	4.41 - 10.95
分析師	n/a
目標價	n/a
股利	n/a
除息日	n/a

關於 ECOR

electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of ...

[閱讀更多]

產業 Medical Devices

類股 Healthcare

IPO 日期 Jun 22, 2018

員工 83

證券交易所 NasdaqCM

股票代號 ECOR

網站 https://www.electrocore.com

完整的公司簡介

財務表現

electroCore 在 2025 年的營收為 32.03M，較前一年的 25.18M 增加 27.2%。淨利為 -13.97M，較前期增加 17.5%。

財務報表

財報驚奇

electroCore 已於 Aug 6, 2026 公布季度財報：

營收為 $9.45M 低於預期 $0, 年增 28.03% 成長.
每股盈餘為 -0.33 超出預期 0.09, 年增 25.00% 成長.

下次財報發布

electroCore Inc. 的下次財報預計於 Nov 4, 2026, 盤中。
分析師預估營收 ... 升級

新聞動態

3 週前 · MarketBeat

electroCore Q2 Earnings Call Highlights

electroCore (NASDAQ:ECOR) reported second-quarter 2026 revenue of $9.5 million, up approximately 28% from $7.4 million a year earlier, as growth in Veterans Affairs prescription sales and direct-to-co...

3 週前 · Zacks

electroCore, Inc. (ECOR) Reports Q2 Loss, Tops Revenue Estimates

electroCore (ECOR) delivered earnings and revenue surprises of +19.51% and +0.92%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

3 週前 · Zacks

Rigel Pharmaceuticals (RIGL) Q2 Earnings Miss Estimates

Rigel (RIGL) delivered earnings and revenue surprises of -3.30% and +14.58%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

3 月前 · MarketBeat

electroCore Touts 30% Growth Outlook, VA Opportunity at LD Micro Conference

electroCore (NASDAQ:ECOR) Interim President and CFO Joshua Lev said the bioelectronic technology company is focused on expanding its non-invasive vagus nerve stimulation platform across federal health...

3 月前 · Motley Fool

electroCore (ECOR) Q1 2026 Earnings Transcript

Thomas Errico: Good afternoon, everyone, and thank you for joining electroCore, Inc.'s first quarter 2026 earnings call. This is the first earnings call since we announced our leadership transition, ...

第 1 頁，共 2 頁

electroCore Inc. (ECOR)